• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Life Sciences - Pharma | News, Analysis, Insights - HIT Consultant

The Future of Digital Transformation in Hospitals

by Ittai Dayan, co-founder & CEO of Rhino Health 04/07/2023 Leave a Comment

The Future of Digital Transformation in Hospitals

Hospitals are increasingly motivated to drive digital transformation in order to improve patient outcomes, reduce costs, meet regulatory requirements and stay competitive. Additionally, digital transformation can support medical research and drive innovation in healthcare, as well as generate new revenue streams. An increasingly important tool as hospitals undergo these transformations is federated learning, a technology that we will expand on later. Federated learning is a machine learning
Read More

HeartFlow Raises $215M for AI-Powered Cardiac Test

by Fred Pennic 04/06/2023 Leave a Comment

What You Should Know: - HeartFlow, Inc., a provider of precision heart care raises $215M in Series F funding round led by Bain Capital Life Sciences with participation from new investor Janus Henderson Investors, and existing investors including Baillie Gifford, Capricorn Investment Group, Hayfin Capital Management, HealthCor, Martis Capital, USVP and Wellington Management. - HeartFlow’s non-invasive personalized cardiac test provides unprecedented visualization of each patient’s coronary arteries, enabling physicians to create more effective treatment plans for their patients. Expansion Plans The HeartFlow product pipeline is expected to continue to propel the company’s position as a precision diagnostics leader. HeartFlow’s additional product launches will enable the company to further support physicians in their commitment to improve cardiovascular patient outcomes. The new funding will enable HeartFlow to meet the growing demand for its commercial products, support a robust body of growing clinical evidence and advance its comprehensive product portfolio to help physicians to diagnose coronary artery disease (CAD) and guide their treatment decisions.

What You Should Know: - HeartFlow, Inc., a provider of precision heart care raises $215M in Series F funding round led by Bain Capital Life Sciences with participation from new investor Janus Henderson Investors, and existing investors including Baillie Gifford, Capricorn Investment Group, Hayfin Capital Management, HealthCor, Martis Capital, USVP and Wellington Management. - HeartFlow’s non-invasive personalized cardiac test provides unprecedented visualization of each patient’s coronary
Read More

Dot Compliance Launches First AI Based ChatGPT Powered eQMS for Life Sciences

by Syed Hamza Sohail 04/05/2023 Leave a Comment

Dot Compliance Launches First AI Based ChatGPT Powered eQMS for Life Sciences

What You Should Know: Dot Compliance, a leading provider of eQMS compliance solutions for the life sciences sector, has introduced an industry-first, ready-to-use AI-Based electronic Quality Management System for life sciences, powered by an embedded generative and predictive artificial intelligence.The system deploys ChatGPT combined with proprietary algorithms to optimize quality processes, automate tasks and help professionals working in quality assurance to focus on what really matters
Read More

Can Technology Live Up to Its Promise for Clinical Trials?

by Stephen Pyke, Chief Clinical Digital and Data Officer, Parexel 04/04/2023 Leave a Comment

Can Technology Live Up to Its Promise for Clinical Trials?

By creating efficiencies with technology, CROs have an opportunity to build clinical trials of the future. For many years, artificial intelligence (AI), machine learning (ML) and natural language processing (NLP) had a reputation in the biopharmaceutical industry as flashy buzzwords, with little concrete evidence to back up their promise. Over time, this lack of understanding has created drawn-out anticipation, leaving many skeptical about the true value of these tools.  As the
Read More

Exploring The Value of Metaverse Use Cases in Life Sciences

by Pratik Maroo, VP - Products, Indegene & Brooke Anderson, Marketing Manager, Omnichannel Activation and Emerging Biotech, Indegene 03/27/2023 Leave a Comment

Exploring The Value of Metaverse Use Cases in Life Sciences

What once seemed like science fiction, interacting with people across the world has become the new normal. While we have become increasingly accustomed to video calls and instant communication in recent years, forays into virtual worlds and extended realities are still relatively novel.  In a post-Covid world, it seems strange to think that video conferences and calls were not the norm only three years ago. But the value created by virtual interactions during the last several years has
Read More

Accenture Report Reveals Staggering Health Inequities and the Role of US Healthcare Ecosystem in Addressing Them 

by Syed Hamza Sohail 03/24/2023 Leave a Comment

New Accenture Report Reveals Staggering Health Inequities and the Role of US Healthcare Ecosystem in Addressing Them

What You Should Know: - Health equity – or the lack thereof – is one of the biggest challenges facing US healthcare organizations today. - A new report from Accenture, US health inequity: beyond the statistics, analyzes the role US healthcare ecosystem participants can play in addressing health inequities due to race and ethnicity. The statistics are staggering.  Analysing Key Trends Concerning Health Inequities  To understand the human and economic
Read More

NVIDIA Unveils Generative AI Service to Advance Life Sciences R&D

by Fred Pennic 03/21/2023 Leave a Comment

NVIDIA Unveils Generative AI Service to Advance Life Sciences R&D

What You Should Know: - NVIDIA today announced an expanded set of generative AI cloud services for customizing AI foundation models to accelerate the creation of new proteins and therapeutics, as well as research in the fields of genomics, chemistry, biology and molecular dynamics. - Part of NVIDIA AI Foundations, the new BioNeMo™ Cloud service offering — for both AI model training and inference — accelerates the most time-consuming and costly stages of drug discovery. It
Read More

Accenture: Data Collaboratives Hold Great Promise for Accelerated Healthcare Progress and Precision Medicine

by Syed Hamza Sohail 03/16/2023 Leave a Comment

Accenture: Data Collaboratives Hold Great Promise for Accelerated Healthcare Progress and Precision Medicine

What You Should Know: - Accenture published Fast-Forwarding Healthcare through Data Collaboratives Report to discover how best health ecosystem players access data to fast-forward healthcare. - Data generated by technical and scientific advances, like connected health devices, consumer health and medical-grade digital apps, individual multi-omics profiling data and the move to cloud storage, holds great promise for accelerated healthcare progress and precision medicine, and data
Read More

A Smarter Approach to Commercial Ecosystems for Superior HCP Experiences

by Susan Hill, VP & General Manager, Customer Engagement at IQVIA 03/08/2023 Leave a Comment

A Smarter Approach to Commercial Ecosystems for Superior HCP Experiences

The commercial life science industry continues to undergo a radical shift in the way it interacts with healthcare providers (HCPs) and consumers. In today’s complex, fast-paced market, traditional life science commercial models no longer cut it.  Fortunately, technology has advanced to enable the agile transition and optimization of customer engagement channels through automation and intelligence-driven workflows. Successful enterprises will leverage these technology advancements to
Read More

Indegene Launches Metaverse Capabilities for Life Sciences Companies

by Fred Pennic 02/22/2023 Leave a Comment

Indegene Partners with Amwell to Customized Digital Patient Engagement

What You Should Know: - Indegene, a digital-first, life sciences commercialization company launches metaverse capabilities to support life sciences organizations with a variety of use cases, including health care provider (HCP) interactions, HCP education, and patient education. - Indegene’s domain expertise will provide life sciences organizations a foundation for navigating the complexity of this emerging technology and the flexibility to create tailored virtual worlds. Using these, life
Read More

  • Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Interim pages omitted …
  • Go to page 28
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |